Published in Neurology on June 01, 1989
Coenzyme Q10 in Huntington's Disease (HD) (2CARE) | NCT00608881
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum Mol Genet (2011) 2.34
Mitochondrial structural and functional dynamics in Huntington's disease. Brain Res Rev (2009) 1.37
Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci (2006) 1.35
Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. Biochim Biophys Acta (2011) 1.16
Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience (2009) 1.14
The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol (1993) 1.13
Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry (1995) 1.05
Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. J Neurol Neurosurg Psychiatry (1992) 0.93
Cognitive and functional decline in Huntington's disease: dementia criteria revisited. Mov Disord (2010) 0.92
Brain morphology and sleep EEG in patients with Huntington's disease. Eur Arch Psychiatry Clin Neurosci (1991) 0.87
Expression analysis of novel striatal-enriched genes in Huntington disease. Hum Mol Genet (2009) 0.85
Protection by glia-conditioned medium in a cell model of Huntington disease. PLoS Curr (2012) 0.83
Clinical severity of Huntington's disease does not always correlate with neuropathologic stage. Mov Disord (2012) 0.79
The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease. J Neurol (2009) 0.78
Huntington's disease: a molecular genetic and CT comparison. J Neurol Neurosurg Psychiatry (1996) 0.75
Ideomotor limb apraxia in Huntington's disease: a case-control study. J Neurol (2008) 0.75
Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry (2007) 5.49
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology (1990) 4.41
Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology (1997) 4.13
Screening for depression in elderly primary care patients. A comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale. Arch Intern Med (1997) 3.77
Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry (1996) 3.61
Huntington disease: clinical care and evaluation. Neurology (1979) 3.54
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology (2000) 2.49
The importance of subsyndromal depression in older primary care patients: prevalence and associated functional disability. J Am Geriatr Soc (1999) 2.48
Homozygotes for Huntington's disease. Nature (1987) 2.40
Potential research participants' views regarding researcher and institutional financial conflicts of interest. J Med Ethics (2004) 2.32
Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. Am J Psychiatry (2001) 2.16
Clinical markers of early disease in persons near onset of Huntington's disease. Neurology (2001) 2.11
Manic syndrome in AIDS. Am J Psychiatry (1991) 2.09
Introduction to background papers for the suggested changes to DSM-IV: cognitive disorders. J Neuropsychiatry Clin Neurosci (1992) 2.04
Pseudodementia. Current concepts and future directions. Arch Gen Psychiatry (1981) 2.03
On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology (1975) 1.96
Completed suicide among older patients in primary care practices: a controlled study. J Am Geriatr Soc (2000) 1.95
Validation of a measure of physical illness burden at autopsy: the Cumulative Illness Rating Scale. J Am Geriatr Soc (1993) 1.83
Weight loss in early stage of Huntington's disease. Neurology (2002) 1.79
Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord (1990) 1.76
Psychiatric disorders in older primary care patients. J Gen Intern Med (1999) 1.70
Gilles de la Tourette syndrome: clinical and family study of 50 cases. Ann Neurol (1980) 1.59
Older age and the underreporting of depressive symptoms. J Am Geriatr Soc (1995) 1.57
Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology (1981) 1.57
Transient global amnesia associated with cerebral angiography performed with use of iopamidol. Radiology (1989) 1.51
Rational suicide and the right to die. Reality and myth. N Engl J Med (1991) 1.50
Age differences in behaviors leading to completed suicide. Am J Geriatr Psychiatry (1998) 1.47
Poor social integration and suicide: fact or artifact? A case-control study. Psychol Med (2004) 1.44
Huntington's disease in Venezuela: neurologic features and functional decline. Neurology (1986) 1.39
Psychiatric syndromes in Huntington's disease. Am J Psychiatry (1983) 1.38
Suicide at 50 years of age and older: perceived physical illness, family discord and financial strain. Psychol Med (2004) 1.38
Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther (1999) 1.35
Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res (1988) 1.28
Suicidal ideation and attempts among rural Chinese aged 16-34 years--socio-demographic correlates in the context of a transforming China. J Affect Disord (2010) 1.24
MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. AJNR Am J Neuroradiol (1999) 1.24
NMDA receptor losses in putamen from patients with Huntington's disease. Science (1988) 1.21
High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique. Neuroradiology (2001) 1.20
Age differences in the personality characteristics of suicide completers: preliminary findings from a psychological autopsy study. Psychiatry (1994) 1.19
Psychological vulnerability to completed suicide: a review of empirical studies. Suicide Life Threat Behav (2001) 1.16
Asymmetries of the cerebral hemispheres on computed tomograms. J Comput Assist Tomogr (1978) 1.15
Age and suicidal ideation in older depressed inpatients. Am J Geriatr Psychiatry (1999) 1.13
Erratic gastric emptying of levodopa may cause "random" fluctuations of parkinsonian mobility. Neurology (1988) 1.13
Interpersonal stressors, substance abuse, and suicide. J Nerv Ment Dis (1993) 1.12
Predictors of nursing home placement in Huntington disease. Neurology (2003) 1.11
Huntington's disease: treatment with dipropylacetic acid and gamma-aminobutyric acid. Neurology (1976) 1.11
Huntington's dementia. Clinical and neuropsychological features. Arch Gen Psychiatry (1978) 1.10
Characterizing the mesencephalon using susceptibility-weighted imaging. AJNR Am J Neuroradiol (2008) 1.09
A neuropsychological comparison of depressed suicide attempters and nonattempters. J Neuropsychiatry Clin Neurosci (2000) 1.09
Computed tomographic localization of the precentral gyrus. Radiology (1980) 1.09
Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations. Ann Neurol (1986) 1.08
Heterogeneous dopamine receptor changes in early and late Huntington's disease. Neurosci Lett (1991) 1.07
Neuroleptic malignant syndrome. Clin Neuropharmacol (1984) 1.07
Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection. Arch Neurol (1996) 1.06
Completed suicide at age 50 and over. J Am Geriatr Soc (1990) 1.05
Functional decline in Huntington's disease. Mov Disord (1995) 1.04
Personality traits and suicidal behavior and ideation in depressed inpatients 50 years of age and older. J Gerontol B Psychol Sci Soc Sci (2000) 1.04
Suicide in later life: psychological autopsy findings. Int Psychogeriatr (1991) 1.00
Tardive dyskinesia in persons with Gilles de la Tourette's disease. Arch Neurol (1981) 0.99
The trial use of clozapine for abnormal involuntary movement disorders. Am J Psychiatry (1979) 0.98
Medical illness burden, trait neuroticism, and depression in older primary care patients. Am J Psychiatry (1998) 0.98
Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants. Neurology (2009) 0.98
Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. Science (1985) 0.98
Parotid and whole saliva in the prediction of serum total and free phenytoin concentrations. Clin Pharmacol Ther (1978) 0.97
Gadolinium-DTPA-enhanced magnetic resonance scanning in cerebellopontine angle tumors. Laryngoscope (1989) 0.95
A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates. Neurology (1995) 0.95
The accuracy of magnetic resonance imaging in patients with suspected multiple sclerosis. The Rochester-Toronto Magnetic Resonance Imaging Study Group. JAMA (1993) 0.95
Suicide and cancer in late life. Hosp Community Psychiatry (1990) 0.94
Magnetic resonance imaging findings in HIV cognitive impairment. Arch Neurol (1990) 0.94
Huntington's disease. A decade of progress. Neurol Clin (1984) 0.93
Neural transplantation: a call for patience rather than patients. Science (1988) 0.93
Familial Tourette's syndrome: report of a large pedigree and potential for linkage analysis. Neurology (1986) 0.92
Case 1, 1989: juvenile-onset parkinsonism, dystonia, and pyramidal tract signs. Mov Disord (1989) 0.91
Arthrosonography: gray-scale ultrasound evaluation of the shoulder. Radiology (1979) 0.91
Homelessness among patients with schizophrenia in rural China: a 10-year cohort study. Acta Psychiatr Scand (2006) 0.91
Family data support a dominant major gene for Tourette syndrome. Psychiatry Res (1988) 0.91
Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia. Ann Neurol (1988) 0.90
Depression and self-reported functional status in older primary care patients. Am J Psychiatry (2001) 0.89
Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism. Neurology (1976) 0.89
Some therapeutic observations in Wilson's disease. Adv Neurol (1983) 0.89
Benzodiazepine and GABA receptors in early Huntington's disease. Neurology (1984) 0.89
Severity of Tourette's syndrome in one large kindred. Implication for determination of disease prevalence rate. Arch Neurol (1987) 0.89
Supratentorial haemangioblastoma: the diagnostic roles of computed tomography and angiography. Clin Radiol (1981) 0.88
Human spinal arachnoid villi and granulations. Neuroradiology (1976) 0.88
Cognitive function and the dexamethasone suppression test in depression. Am J Psychiatry (1984) 0.88
Myoclonus and dystonia: a family study. Adv Neurol (1988) 0.88
Neurodegenerative disorders and aging. Alzheimer's disease and Parkinson's disease--common ground. Ann N Y Acad Sci (1988) 0.88
Knowledge of the Genetic Information Nondiscrimination act among individuals affected by Huntington disease. Clin Genet (2012) 0.87
Brain magnetic resonance diffusion abnormalities in Creutzfeldt-Jakob disease. Arch Neurol (1997) 0.87
An outline for the analysis of dementia. The memory disorder of Huntingtons disease. Neurology (1977) 0.87
Effectiveness of a nationwide aftercare program for suicide attempters. Psychol Med (2012) 0.87
Long-term experience with pergolide therapy of advanced parkinsonism. Neurology (1985) 0.87
Suicidal thoughts and behaviors in older adults in rural China: a preliminary study. Int J Geriatr Psychiatry (2012) 0.87
A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. J Clin Psychopharmacol (1983) 0.86
Thrombogenicity of heparin- and non-heparin-coated catheters: clinical trail. AJR Am J Roentgenol (1982) 0.86
Spinal cord compression in diffuse idiopathic skeletal hyperostosis. Radiology (1982) 0.86
Bromocriptine inhibits norepinephrine release. Clin Pharmacol Ther (1979) 0.86